Merck & Co.

Merck & Co. (MSD) scientists joined the lab on an electroaffinity labelling platform for target identification and on a scalable total synthesis of saxitoxin, bringing world-class process and chemical biology expertise to both.

Rahway, New Jersey · Known as MSD outside the United States and Canada.

Papers together
2
Years
2023–2025
Co-authors
8
The record

All 2 papers with Merck & Co.

All partners →
  1. Scalable Total Synthesis of Saxitoxin and Related Natural Products

    Nature 2025 · doi:10.1038/s41586-025-09551-5 · In our publications

  2. An Electroaffinity Labelling Platform for Chemoproteomic-Based Target Identification

    Nat. Chem. 2023 · doi:10.1038/s41557-023-01240-y · In our publications

    • Merck & Co. Aleksandra Olow, Keun Ah Ryu, La-Tonya A. Adams, Lee R. Roberts, Olugbeminiyi Fadeyi, Rob Oslund
    • InduPro Therapeutics Olugbeminiyi Fadeyi, Rob Oslund

Our co-authors at Merck & Co.

La-Tonya A. AdamsOlugbeminiyi FadeyiAleksandra OlowRob OslundChristopher K. PrierLee R. RobertsKeun Ah RyuKai-Jiong Xiao

Some of these papers were shared with 2 other partners: Debut Biotechnology, InduPro Therapeutics.

Work with us

Interested in collaborating with the Baran lab?

If your team has a problem that matters, a molecule no one can make, a reaction that will not scale, a reagent that should exist, we would love to hear about it.

Email Phil

or write to pbaran@scripps.edu